Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18392 | 27166128 | Am J Gastroenterol | Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study. | 2016 | Details |
| A18393 | 27164963 | Chin J Integr Med | Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. | 2016 | Details |
| A18394 | 27164417 | Int J Cardiol | Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis. | 2016 | Details |
| A18395 | 27164079 | Int J Mol Sci | Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin. | 2016 | Details |
| A18396 | 27161854 | Scand J Gastroenterol | Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. | 2016 | Details |
| A18397 | 27161518 | J Diabetes Complications | Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2016 | Details |
| A18398 | 27160697 | Dig Liver Dis | Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients. | 2016 | Details |
| A18399 | 27158393 | Am J Transl Res | Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A18400 | 27158205 | World J Gastroenterol | Non-alcoholic fatty liver disease is not associated with a lower health perception. | 2016 | Details |
| A18401 | 27157992 | Am J Pathol | Lipid-Induced Endoplasmic Reticulum Stress Impairs Selective Autophagy at the Step of Autophagosome-Lysosome Fusion in Hepatocytes. | 2016 | Details |
| A18402 | 27155918 | J Nutr Biochem | Intake of a Western diet containing cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity and hepatic lipid accumulation in mice. | 2016 | Details |
| A18403 | 27155553 | Clin Gastroenterol Hepatol | Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression. | 2016 | Details |
| A18405 | 27154894 | N C Med J | Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18406 | 27152979 | J Med Food | Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model. | 2016 | Details |
| A18408 | 27153234 | Chemosphere | Metabolic and immune impairments induced by the endocrine disruptors benzo[a]pyrene and triclosan in Xenopus tropicalis. | 2016 | Details |
| A18409 | 27152734 | Curr Opin Clin Nutr Metab Care | Sugar and metabolic health: is there still a debate? | 2016 | Details |
| A18410 | 27152074 | Clujul Med | Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles. | 2016 | Details |
| A18411 | 27151181 | J Hepatol | Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease. | 2016 | Details |
| A18412 | 27151177 | J Hepatol | Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. | 2016 | Details |
| A18413 | 27150853 | Intern Med | Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A18414 | 27150500 | Scand J Gastroenterol | The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients. | 2016 | Details |
| A18417 | 27148532 | Front Cell Dev Biol | Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease. | 2016 | Details |
| A18418 | 27147819 | Integr Med Insights | The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A18420 | 27146015 | Annu Rev Nutr | Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. | 2016 | Details |
| A18421 | 27146014 | Annu Rev Nutr | Hormonal and Metabolite Regulation of Hepatic Glucokinase. | 2016 | Details |
| A18422 | 27146012 | Annu Rev Nutr | Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus. | 2016 | Details |
| A18423 | 27145114 | Mol Nutr Food Res | Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. | 2016 | Details |
| A18424 | 27145007 | Endocrinology | Maternal Hyperleptinemia Improves Offspring Insulin Sensitivity in Mice. | 2016 | Details |
| A18425 | 27143995 | Oxid Med Cell Longev | Hepatocyte Growth Factor Reduces Free Cholesterol-Mediated Lipotoxicity in Primary Hepatocytes by Countering Oxidative Stress. | 2016 | Details |
| A18426 | 27143968 | Int J Endocrinol | Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats. | 2016 | Details |
| A18427 | 27143762 | Poult Sci | Therapeutic effect of flax-based diets on fatty liver in aged laying hens. | 2016 | Details |
| A18428 | 27143495 | Prev Med | Impact of physical activity on nonalcoholic steatohepatitis in people with nonalcoholic simple fatty liver: A prospective cohort study. | 2016 | Details |
| A18429 | 27142870 | Diabetes Metab | Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? | 2016 | Details |
| A18430 | 27142744 | J Nutr Biochem | Liquid fructose in pregnancy exacerbates fructose-induced dyslipidemia in adult female offspring. | 2016 | Details |
| A18431 | 27142736 | J Nutr Biochem | Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoE(shl) mice deficient in apolipoprotein E expression. | 2016 | Details |
| A18432 | 27142672 | Dig Dis Sci | Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. | 2016 | Details |
| A18434 | 27142096 | Indian J Gastroenterol | Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant program. | 2016 | Details |
| A18435 | 27138082 | J Psychiatr Pract | Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. | 2016 | Details |
| A18436 | 27136390 | Mol Nutr Food Res | Nutritional depletion in n-3 PUFA in apoE knock-out mice: A new model of endothelial dysfunction associated with fatty liver disease. | 2016 | Details |
| A18437 | 27135827 | PLoS One | A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. | 2016 | Details |
| A18439 | 27134667 | Therap Adv Gastroenterol | Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. | 2016 | Details |
| A18440 | 27134062 | Nutr Metab Cardiovasc Dis | Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk. | 2016 | Details |
| A18441 | 27132506 | Oncogene | Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma. | 2016 | Details |
| A18442 | 27131942 | Rev Gastroenterol Peru | [Non alcoholic steatohepatitis (NASH)]. | 2017 | Details |
| A18443 | 30133212 | Zhong Yao Cai | [Protection of Fufang Zhenzhu Tiaozhi Formula on NAFLD in Mice by Regulating ERS]. | 2016 | Details |
| A18444 | 29182828 | Lijec Vjesn | APPROACH TO THE PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE. | 2016 | Details |
| A18445 | 29182821 | Rinsho Byori | [Present State of Non-B Non-C Liver Disease-and Its Monitoring.] | 2016 | Details |
| A18446 | 29182819 | Rinsho Byori | [The Latest Findings in Liver Diseases -Chairman's Introductory Remarks.] | 2016 | Details |
| A18447 | 28891620 | Zhongguo Zhong Yao Za Zhi | [Experimental study of Tangshen formulain improved lipid metabolism and phenotypic switch of macrophage in db/db mice]. | 2016 | Details |
| A18448 | 27128911 | Int J Mol Sci | Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review. | 2016 | Details |
| A18449 | 27128907 | Int J Mol Sci | PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18450 | 27128842 | PLoS One | Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis. | 2016 | Details |
| A18451 | 27126072 | Biochimie | Hepatosteatosis and estrogen increase apolipoprotein O production in the chicken. | 2016 | Details |
| A18452 | 27125895 | AAPS J | Dual Outcomes of Rosiglitazone Treatment on Fatty Liver. | 2016 | Details |
| A18453 | 27124954 | Genome Med | Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. | 2016 | Details |
| A18454 | 27124606 | J Cardiovasc Pharmacol | Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial. | 2016 | Details |
| A18455 | 27123846 | PLoS One | Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18456 | 27123461 | J Diabetes Res | The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes. | 2016 | Details |
| A18457 | 27122660 | World J Gastroenterol | Nonalcoholic fatty liver disease as a multi-systemic disease. | 2016 | Details |
| A18458 | 27121255 | Int J Obes (Lond) | Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice. | 2016 | Details |
| A18459 | 27121253 | Int J Obes (Lond) | Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation. | 2016 | Details |
| A18460 | 27117865 | Lipids | Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias. | 2016 | Details |
| A18461 | 27116542 | Int J Cancer | Tobacco carcinogen induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation. | 2016 | Details |
| A18462 | 27113292 | Nutr Metab Cardiovasc Dis | The innovative "Bio-Oil Spread" prevents metabolic disorders and mediates preconditioning-like cardioprotection in rats. | 2016 | Details |
| A18463 | 27111464 | J Appl Microbiol | Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice. | 2016 | Details |
| A18464 | 27110380 | BMJ Open Gastroenterol | Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease. | 2016 | Details |
| A18465 | 27110379 | BMJ Open Gastroenterol | Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH). | 2016 | Details |
| A18466 | 27110262 | Hepat Mon | Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. | 2016 | Details |
| A18467 | 27109475 | Biochem Biophys Res Commun | AMPKα1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. | 2016 | Details |
| A18468 | 27109453 | Diabetes Obes Metab | Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers. | 2016 | Details |
| A18469 | 27109162 | Am J Chin Med | Rheum palmatum L. Attenuates High Fat Diet-Induced Hepatosteatosis by Activating AMP-Activated Protein Kinase. | 2016 | Details |
| A18470 | 27107966 | Best Pract Res Clin Obstet Gynaecol | Hepatic manifestations of women with polycystic ovary syndrome. | 2016 | Details |
| A18471 | 27107702 | Biochem Biophys Res Commun | MicroRNA-421 induces hepatic mitochondrial dysfunction in non-alcoholic fatty liver disease mice by inhibiting sirtuin 3. | 2016 | Details |
| A18472 | 27106721 | Diabetologia | Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial. | 2016 | Details |
| A18473 | 27105827 | Nutr J | Pathophysiological role of host microbiota in the development of obesity. | 2016 | Details |
| A18474 | 27105497 | Oncotarget | Abnormal lipid processing but normal long-term repopulation potential of myc-/- hepatocytes. | 2016 | Details |
| A18475 | 27104887 | J Physiol | Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis. | 2016 | Details |
| A18476 | 27104558 | Nutrients | Insulin Protects Hepatic Lipotoxicity by Regulating ER Stress through the PI3K/Akt/p53 Involved Pathway Independently of Autophagy Inhibition. | 2016 | Details |
| A18477 | 27104526 | Int J Mol Sci | NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? | 2016 | Details |
| A18478 | 27103143 | BMC Genomics | Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice. | 2016 | Details |
| A18479 | 27102725 | Liver Int | The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A18480 | 27102566 | Br J Nutr | Healthy dietary pattern is inversely associated with non-alcoholic fatty liver disease in elderly. | 2016 | Details |
| A18482 | 27100443 | Medicine (Baltimore) | The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18484 | 27101131 | Diabetologia | Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. | 2016 | Details |
| A18485 | 27099853 | Adv Biomed Res | Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients. | 2016 | Details |
| A18486 | 27099536 | Hepat Med | Autophagy: a new target for nonalcoholic fatty liver disease therapy. | 2016 | Details |
| A18487 | 27099265 | Eur Heart J | Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? | 2016 | Details |
| A18488 | 27096691 | J Pharm Pharm Sci | Non-Alcoholic Steatohepatitis: Clinical and Translational Research. | 2016 | Details |
| A18489 | 27096315 | Immunity | Getting the Skinny on CD4(+) T Cell Survival in Fatty Livers. | 2016 | Details |
| A18490 | 27095770 | Zhonghua Gan Zang Bing Za Zhi | [Which animal models of nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) have more practical value in experimental investigations?]. | 2016 | Details |
| A18491 | 27095767 | Zhonghua Gan Zang Bing Za Zhi | [Effect of chitooligosaccharide on hepatic triglyceride metabolism and related mechanisms]. | 2016 | Details |
| A18492 | 27091791 | J Hepatol | Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. | 2016 | Details |
| A18493 | 27091480 | Immunol Lett | Clinical laboratory standard capillary protein electrophoresis alerted of a low C3 state and lead to the identification of a Factor I deficiency due to a novel homozygous mutation. | 2016 | Details |
| A18494 | 27091184 | Diabetologia | Diagnosis of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A18495 | 27091156 | Cell Mol Life Sci | Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease. | 2016 | Details |
| A18497 | 27091074 | Sci Rep | Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD. | 2016 | Details |
| A18498 | 27090939 | Biochim Biophys Acta | Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis. | 2016 | Details |
| A18499 | 27089731 | Lik Sprava | [THE EFFECTIVENESS OF THE MODERN IMMUNOACTIVE PREPARATION IMMUNOFAN FOR MEDICAL REHABILITATION OF PATIENTS WITH NONALCOHOLIC STEATOHEPATITISIS AGAINST NEUROCIRCULATORY DYSTONIA, AFTER INFECTIOUS MONONUCLEOSIS]. | 2016 | Details |
| A18500 | 27089408 | J Pediatr Endocrinol Metab | Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children. | 2016 | Details |
| A18501 | 27089331 | Int J Mol Sci | NAFLD and Chronic Kidney Disease. | 2016 | Details |